Company Filing History:
4 out of 134 
4 out of 4 
1 out of 1 Years Active: 2022-2025
Title: Innovations of Matthias Johannes Eiber
Introduction
Matthias Johannes Eiber is a notable inventor based in Vaterstetten, Germany. He has made significant contributions to the field of medical technology, particularly in the development of radiotracers and therapeutics. With a total of five patents to his name, Eiber's work is recognized for its innovative approach to addressing disease-relevant target molecules.
Latest Patents
One of Eiber's latest patents is focused on a dual mode radiotracer and therapeutics. This invention relates to a ligand-SIFA-chelator conjugate, which comprises three separate moieties within a single molecule. These moieties include one or more ligands capable of binding to a disease-relevant target molecule, a silicon-fluoride acceptor (SIFA) moiety that features a covalent bond between a silicon atom and a fluorine atom, and one or more chelating groups that may contain a chelated nonradioactive or radioactive cation.
Career Highlights
Eiber has had a distinguished career, working at prestigious institutions such as the Technical University of Munich and the Klinikum Rechts der Isar. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Eiber's notable coworkers include Alexander Josef Wurzer and Hans-Jürgen Wester. Their collaborative efforts have further advanced the research and development of innovative medical technologies.
Conclusion
Matthias Johannes Eiber's contributions to the field of medical technology through his patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in the development of effective therapeutics and diagnostic tools.